Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Yuliya Lytvyn"'
Publikováno v:
Drugs in Context, Vol 11, Pp 1-12 (2022)
Psoriasis is a chronic inflammatory skin condition that affects diverse ethnic groups with a wide spectrum of skin colours. There are significant differences in how psoriasis presents and impacts the quality of life in non-White individuals. Genetic
Externí odkaz:
https://doaj.org/article/e17a4f3df6bc4a60a6a3126c63a62c11
Autor:
Yuliya Lytvyn, PhD, Katherine McDonald, MD, Asfandyar Mufti, MD, Jennifer Beecker, MD, CCFP (EM), FRCPC, FAAD
Publikováno v:
JAAD International, Vol 6, Iss , Pp 125-142 (2022)
Over 1 million isotretinoin prescriptions are authorized in the United States per year. An insight into the frequency, dose dependency, timing, and reversibility of hair loss associated with isotretinoin treatment for acne vulgaris could help guide d
Externí odkaz:
https://doaj.org/article/bc810fdf3c1b46a197985dc85ab47ee9
Autor:
Yuliya Lytvyn, PhD, Asfandyar Mufti, MD, Hiba Zaaroura, MD, Muskaan Sachdeva, BHSc, Justin D. Lu, MSc, Brian D. Rankin, PhD, Vimal H. Prajapati, MD, Ronald Vender, MD, Jensen Yeung, MD, FRCPC
Publikováno v:
JAAD International, Vol 6, Iss , Pp 3-5 (2022)
Externí odkaz:
https://doaj.org/article/e5569883aea8428a970c97f32babd322
Autor:
Asfandyar Mufti, MD, Yuliya Lytvyn, PhD, Abrahim Abduelmula, BScN, Patrick Kim, BHSc, Muskaan Sachdeva, BHSc, Jensen Yeung, MD, FRCPC
Publikováno v:
JAAD International, Vol 3, Iss , Pp 18-22 (2021)
Externí odkaz:
https://doaj.org/article/d65ed9b7463a4b30b7b757e385fc0e82
Autor:
Yuliya Lytvyn, PhD, Hiba Zaaroura, MD, Asfandyar Mufti, MD, Shaikhah AlAbdulrazzaq, MD, Jensen Yeung, MD, FRCPC
Publikováno v:
JAAD International, Vol 4, Iss , Pp 49-51 (2021)
Externí odkaz:
https://doaj.org/article/92a53448859f4edcbcabc44cb69646da
Autor:
Yuliya Lytvyn, Melinda Gooderham
Publikováno v:
Pharmaceutics, Vol 15, Iss 2, p 568 (2023)
Atopic dermatitis (AD) is a common chronic inflammatory skin condition that has a significant impact on a patient’s quality of life and requires ongoing management. Conventional topical and systemic therapies do not target specific components of AD
Externí odkaz:
https://doaj.org/article/355688ebe16f4672bd3d0f9311e6166c
Autor:
Yuliya Lytvyn, Asfandyar Mufti, Abrahim Abduelmula, Muskaan Sachdeva, Khalad Maliyar, Jorge R. Georgakopoulos, Jensen Yeung
Publikováno v:
Pharmaceutics, Vol 14, Iss 11, p 2452 (2022)
Atopic dermatitis (AD) is a common skin condition characterized by inflammation that presents with erythematous and pruritic skin. Its chronic relapse-remitting nature has a significant impact on the quality of life, and often requires ongoing manage
Externí odkaz:
https://doaj.org/article/c741dffc7b64416aa66cb4e444c0ecdc
Autor:
Daniel Scarr, Petter Bjornstad, Leif E. Lovblom, Julie A. Lovshin, Genevieve Boulet, Yuliya Lytvyn, Mohammed A. Farooqi, Vesta Lai, Andrej Orszag, Alanna Weisman, Hillary A. Keenan, Michael H. Brent, Narinder Paul, Vera Bril, David Z.I. Cherney, Bruce A. Perkins
Publikováno v:
Kidney International Reports, Vol 4, Iss 6, Pp 786-796 (2019)
Introduction: Glomerular filtration rate (GFR) is routinely used for clinical assessment of kidney function. However, the accuracy of estimating equations in older adults is uncertain. Methods: In 66 adults with ≥50 years type 1 diabetes (T1D) dura
Externí odkaz:
https://doaj.org/article/c292c75b1ebd4628986a5c56d7f5c87f
Autor:
Nigar Sekercioglu, Leif Erik Lovblom, Petter Bjornstad, Julie A. Lovshin, Yuliya Lytvyn, Geneviève Boulet, Mohammed A. Farooqi, Andrej Orszag, Vesta Lai, Josephine Tse, Leslie Cham, Hillary A. Keenan, Michael H. Brent, Narinder Paul, Vera Bril, Bruce A. Perkins, David Z. I. Cherney
Publikováno v:
Renal Failure, Vol 41, Iss 1, Pp 427-433 (2019)
Objectives: Diabetic kidney disease (DKD) is an independent predictor of cardiovascular morbidity and mortality in type 1 diabetes (T1D). We aimed to explore clinical and biochemical factors, including the achievement of American Diabetes Association
Externí odkaz:
https://doaj.org/article/e5474eaf563e403b8c103cc886b356e5
Autor:
David Cherney, Bruce A Perkins, Yuliya Lytvyn, Hiddo Heerspink, María E Rodríguez-Ortiz, Harald Mischak
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0186910 (2017)
Treatment with empagliflozin, an inhibitor of the sodium/glucose cotransporter 2 (SGLT2), is associated with slower progression of diabetic kidney disease. In this analysis, we explored the hypothesis that empagliflozin may have an impact on urinary
Externí odkaz:
https://doaj.org/article/a4975242b9d24f128f02541c4553111c